|  Help  |  About  |  Contact Us

Comment :

Type  MGI:General Description  all pIpC-treated mice develop myeloproliferative disease (MPD) Mac-1+/Gr-1+ mature myeloid cells are increased 5 of 27 pIpC-treated mice exhibit accelerated MPD